How Real-World Evidence is Rewriting the Rules of Commercial Pharma
The gold standard for drug approval has always been the Randomized Controlled Trial (RCT). These trials, conducted in highly controlled environments, provide the robust evidence necessary for regulatory submission. Yet, commercial success in the multi-trillion-dollar pharmaceutical market depends less on controlled efficacy and more on real-world effectiveness. Today, commercial pharma strategy is undergoing a fundamental […]